Asymptomatic hepatitis G virus infection in blood donors

BACKGROUND: Hepatitis G virus (HGV) has been reported in patients with fulminant hepatitis and aplastic anemia, but HGV RNA has also been found in healthy individuals. The possible associations of HGV with liver function and hematologic abnormalities in asymptomatic blood donors were investigated. STUDY DESIGN AND METHODS: Serum HGV RNA was determined in 200 repeat donors (Group A), 44 subjects with elevated alanine aminotransferase (Group B), and 54 hepatitis C virus carriers (Group C). Liver histology was evaluated in Group C by using the histologic activity index. RESULTS: HGV RNA was detected in three subjects of Group A (1.5%; 95% CI: 0.3–4.3), two of Group B (4.5%; 95% CI: 0.6–15.5%), and six of Group C (11.1%; 95% CI: 4.2–22.6). The prevalence of leukopenia and elevated gamma‐glutamyl transpeptidase was higher in the 11 viremic donors than in 88 nonviremic subjects (36% vs. 2.3%, and 55% vs. 22%, respectively; p < 0.05), matched for clinical and demographic characteristics. The mean histologic activity index score +/− standard error was 4 +/− 0.7 in the HGV RNA‐positive donors and 3.4 +/− 0.3 in the HGV RNA‐negative donors. CONCLUSION: HGV is endemic in Italian blood donors, although it has a limited role in causing liver damage. Further studies are needed to clarify its role in inducing transfusion‐associated disease in myelosuppression.

[1]  H. Margolis,et al.  Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team. , 1997, The New England journal of medicine.

[2]  A. Zanella,et al.  The incidence and risk factors of community‐acquired hepatitis C in a cohort of Italian blood donors , 1997, Hepatology.

[3]  T. Surowy,et al.  An ELISA for detection of antibodies to the E2 protein of GB virus C. , 1997, The Journal of infectious diseases.

[4]  K. Stark,et al.  Detection of antibodies to a putative hepatitis G virus envelope protein , 1997, The Lancet.

[5]  M. Brunetto,et al.  Hepatitis G virus RNA in the serum of patients with elevated gamma glutamyl transpeptidase and alkaline phosphatase: a specific liver disease , 1996 .

[6]  J. Sheu,et al.  A prospective study of transfusion-transmitted GB virus C infection: similar frequency but different clinical presentation compared with hepatitis C virus. , 1996, Blood.

[7]  J W Shih,et al.  Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. , 1996, The New England journal of medicine.

[8]  H. Alter.  The cloning and clinical implications of HGV and HGBV-C. , 1996, The New England journal of medicine.

[9]  K. Masuko,et al.  Infection with hepatitis GB virus C in patients on maintenance hemodialysis. , 1996, New England Journal of Medicine.

[10]  K. Korn,et al.  Molecular evidence for transmission of hepatitis G virus by blood transfusion , 1996, The Lancet.

[11]  H. Margolis,et al.  Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent , 1996, Science.

[12]  H. Okamoto,et al.  Hepatitis G infection in drug abusers with chronic hepatitis C. , 1996, The New England journal of medicine.

[13]  M. Colombo,et al.  Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection. , 1996, Gastroenterology.

[14]  S. Mishiro,et al.  Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology , 1995, The Lancet.

[15]  T. Pilot‐Matias,et al.  Isolation of novel virus-like sequences associated with human hepatitis , 1995, Nature Medicine.

[16]  A. Zanella,et al.  Hepatitis C virus RNA and liver histology in blood donors reactive to a single antigen by second‐generation recombinant immunoblot assay , 1995, Hepatology.

[17]  R. Poupon,et al.  Prevalence, severity, and risk factors of liver disease in blood donors positive in a second‐generation anti—hepatitis C virus screening test , 1995, Hepatology.

[18]  A. Albertini,et al.  Distribution of viral genotypes in Italy determined by hepatitis C virus typing by DNA immunoassay , 1994, Journal of clinical microbiology.

[19]  A. Zanella,et al.  Determination of Hepatitis C Virus RNA in the Serum by the Amplicor HCV PCR Kit , 1994, Vox sanguinis.

[20]  J. Hoofnagle,et al.  Classification of chronic hepatitis: Diagnosis, grading and staging , 1994, Hepatology.

[21]  N. Hayashi,et al.  Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels , 1994, Hepatology.

[22]  L. Stuyver,et al.  Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. , 1993, The Journal of general virology.

[23]  M. Houghton,et al.  T-lymphocyte response to hepatitis C virus in different clinical courses of infection. , 1993, Gastroenterology.

[24]  A. Alberti,et al.  Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV , 1992, The Lancet.

[25]  S. Halstead.  Dengue: hematologic aspects. , 1982, Seminars in hematology.

[26]  Neil Kaplowitz,et al.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis , 1981, Hepatology.